Objective:

To share insights and clinical best practices in cancer treatment and research, focusing on innovative therapies and patient care strategies, at the NCCN 2026 Annual Conference.

Key Findings:

• SurVaxM shows promise in early-stage clinical trials for neuroendocrine tumors, potentially improving patient outcomes.
• The impact of nurse coordinators on care documentation is being evaluated, which may enhance care quality.
• Machine learning models are being developed to predict depression in cancer patients, aiming to improve mental health support.

Interpretation:

The presentations highlight advancements in cancer treatment and the importance of patient-centered care in oncology.

Limitations:

• Details on the outcomes of the presented studies, particularly those by Dr. Dergham and Dr. Young, are not fully disclosed in the announcement.
• The conference format may limit in-depth discussion of findings, potentially affecting audience understanding.

Conclusion:

Roswell Park's participation underscores its commitment to advancing cancer care and research through collaboration, innovation, and sharing of critical insights at a national level.